History of the research laboratory (medicinal and environmental toxicology) of the Military medical academy named after S.M. Kirov

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

This paper presents the history of the formation of the Research Department of the Experimental Medicine of the Research Center of the Military Medical Academy named after S.M. Kirov. The department is the only division of the academy that conducts experiments on animal models and field tests using laboratory animals in the interests of the Armed Forces of the Russian Federation. The paper also presents the main scientific achievements and development prospects of one of the three laboratories of the department — Research Laboratory of Medicinal and Environmental Toxicology. In the direction of “drug toxicology,” the laboratory staff worked for >15 years in cooperation with the Scientific Center of the Russian Academy of Sciences (Pushchino) on the problems of perfluorocarbon-based blood substitutes. The results of the study helped deepen the understanding of the mechanisms of the physiological activity of perfluorocarbon emulsions and the expansion of the areas of clinical application of perftoran. The ecotoxicological direction of scientific research is represented by two large-scale cycles of scientific studies. The first was devoted to the medical support of oil refining to increase the protection of personnel who have been professionally exposed to toxic chemicals from the damage caused by chemical accidents. The second area of environmental research, which has been significantly updated in recent years, is devoted to the study of remote environmental and biomedical consequences of the use of chemical weapons by the US Army in the period from 1966 to 1972 in Vietnam. In recent years, the laboratory has focused on problems related to the search and development of new radiation countermeasure agents including biotechnological products and their compositions. Studies are also being conducted to improve the complex therapy of patients with sepsis, in which methods of extracorporeal blood purification are used in the treatment. These works are relevant for military and civilian health care and are performed in cooperation with the departments of the academy and several leading research organizations in St. Petersburg.

全文:

受限制的访问

作者简介

Genrikh Sofronov

Military Medical Academy named after S.M. Kirov of the Ministry of Defense of the Russian Federation

Email: gasofronov@mail.ru
ORCID iD: 0000-0002-8587-1328
SPIN 代码: 7334-4881

doctor of medical sciences, professor

俄罗斯联邦, Saint Petersburg

Elena Murzina

Military Medical Academy named after S.M. Kirov of the Ministry of Defense of the Russian Federation

编辑信件的主要联系方式.
Email: elenmurzina@mail.ru
ORCID iD: 0000-0001-7052-3665
SPIN 代码: 5188-0797

candidate of biological sciences

俄罗斯联邦, Saint Petersburg

Alexey Denisov

Military Medical Academy named after S.M. Kirov of the Ministry of Defense of the Russian Federation

Email: denav80@mail.ru
ORCID iD: 0000-0002-8846-973X
SPIN 代码: 6969-0759

candidate of medical sciences

俄罗斯联邦, Saint Petersburg

Olga Veselova

Military Medical Academy named after S.M. Kirov of the Ministry of Defense of the Russian Federation

Email: veselova28@mail.ru
SPIN 代码: 4864-8391

research associate

俄罗斯联邦, Saint Petersburg

Tat'yana Krylova

Military Medical Academy named after S.M. Kirov of the Ministry of Defense of the Russian Federation

Email: vmeda-nio@mil.ru
SPIN 代码: 3797-6757

candidate of biological sciences

俄罗斯联邦, Saint Petersburg

参考

  1. Professora Voenno-medicinskoj (мediko-hirurgicheskoj) akademii. Belevitin AB. editor. Saint Peterburg; 2008. 313 p. (In Russ.).
  2. Belskikh AN, Basharin VA, Krylova TG. Academician genrikh aleksandrovich sofronov (to the 80th anniversary of his birth) Bulletin of the Russian Military Medical Academy. 2016;55(3):273–276. (In Russ.).
  3. Pshenkina NN, Andreeva NB, Murzina EV, et al. Pharmacokinetics of ampicillin and amitriptyline in conditions of preliminnary perftoran infusion. Bulletin of the Russian Military Medical Academy. 2005;14(1):25–30. (In Russ.).
  4. Pshenkina NN, Andreeva NB, Murzina EV, et al. Analysis of the effect of perfluorane on the pharmacokinetics of some drugs. General Reanimatology. 2007;3(3–1):25–30. (In Russ.).
  5. Pshenkina NN, Veselova OM, Murzina EV, Sofronov GA. Investigation of drugs’ adsorption by the perfluorane. General Reanimatology. 2011;7(2):56–60. (In Russ.).
  6. SHilov VV, Polozova EV. Primenenie emul’sii perftoruglerodov dlya lecheniya endotoksikoza pri ostryh otravleniyah karbofosom i psihotropnymi lekarstvennymi preparatami. Perftororganicheskie soedineniya v biologii i medicine. Pushchino; 2001. P. 180–190. (In Russ.).
  7. Krylov PK, Cepkov AA, Buryakova LV. Optimizaciya skhemy primeneniya perftorana pri lechenii postradavshih s neobshirnymi ozhogami. Emergency Medical Care. 2011;12(3):8–12. (In Russ.).
  8. Perevedentseva EV, Zaritskiy AR, Fok MV, Kuznetsova IN. Perfluorocarbon emulsions increase transfer of oxygen in plasma from erythrocyte to tissues. Artificial Cells Blood Substitutes and Immobilization Biotechnology. 1998;26(2):223–229. doi: 10.3109/10731199809119780
  9. Sofronov GA, Krylov KM, Shlyk IV, et al. Ispol’zovanie perftorana v infuzionno-transfuzionnoj terapii ostrogo perioda ozhogovoj bolezni: posobie dlya vrachej. Saint Peterburg: Stiks; 2010. (In Russ.)
  10. Gorichny VA, Yazenok AV, Ivanov MB, et al. Risk assessment for cardiovascular diseases in personnel of chemically hazardous objects. Bulletin of the Russian Military Medical Academy. 2015;(2):96–99. (In Russ.).
  11. Gorichny VA, Serdukov DYu, Yazenok AV, et al. Risk factors for the development of initial manifestations of atherogenic cardiovascular diseases in personnel of chemically hazardous facilities. Toxicological Review. 2017;(4):2–7. (In Russ.). doi: 10.36946/0869-7922-2017-4-2-7
  12. Rumak VS, Umnova NV, Sofronov GA, Pavlov DS. Molecular toxicology of dioxins. Saint Petersburg: Nauka; 2013. 63 p. (In Russ.)
  13. Rumak VS, Pavlov DS, Sofronov GA. Environment and human health in regions contaminated with dioxins Vietnam. Moscow: IPEE Severcova AN. RAN; 2011. (In Russ.).
  14. Murzina EV, Sofronov GA, Aksenova NV, et al. Experimental estimation of the radioprotective efficiency of recombinant flagellin. Bulletin of the Russian Military Medical Academy. 2017;59(3):122–128. (In Russ.).
  15. Murzina EV, Sofronov GA, Simbirtsev AS, et al. Radioprotective efficiency of recombinant flagellin and interleukin-1 beta with combined administration. Pharm Chem J. 2019;52(10):835–838. doi: 10.1007/s11094-019-1910-1
  16. Murzina EV, Sofronov GA, Simbirtsev AS, et al. Experimental evaluation of the effect of beta-D-glucan on the survival of irradiated mice. Medical Academic Journal. 2020;20(2):59–68. (In Russ.). doi: 10.17816/MAJ34161
  17. Buryakova LV, Lazarenko DYu, Krylova TG. Dynamics of clinical and laboratory indicators in patients with sepsis when using antibacterial therapy and extracorporeal detoxication methods. Izvestia of the Russian Military Medical Academy. 2020;39(S3–2):5–10. (In Russ.).
  18. Marukhov AV, Murzina EV, Zakharov MV, et al. Evaluation of plasma levels of meropenem in septic patients during extracorporeal blood purification. Medical Academic Journal. 2020;20(4):81–94. (In Russ.) doi: 10.17816/MAJ54636

补充文件

附件文件
动作
1. JATS XML

版权所有 © Sofronov G.A., Murzina E.V., Denisov A.V., Veselova O.M., Krylova T.G., 2021

Creative Commons License
此作品已接受知识共享署名-非商业性使用-禁止演绎 4.0国际许可协议的许可。

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 77762 от 10.02.2020.


##common.cookie##